Integrated Device Technology, Inc. ( IDT ® )
(NASDAQ:IDTI) today introduced a new low-distortion, low-power radio
frequency (RF) mixer, delivering RF technology that reduces distortion
in LTE and TDD systems while minimizing power consumption.
THIRD-QUARTER REVENUE UP 8.9%; NINE MONTHS UP 5.8% NINE-MONTHS INCOME FROM CONTINUING OPERATIONS UP 11.7%; EPS $0.61 NINE-MONTHS ADJUSTED EPS $0.64 EXCLUDING SHARE COUNT IMPACT OF CONVERTIBLE NOTES
CLEVELAND , Oct.
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced positive top-line results from its Phase 2b placebo-controlled
trial of AKB-6548 in non-dialysis patients with anemia related to
chronic kidney disease (CKD). The study achieved its primary endpoint
and AKB-6548 was generally well tolerated, confirming that the
once-daily, oral therapy can successfully increase and maintain
hemoglobin (HGB) levels.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.